Earlier this month, Therigy presented a new poster abstract at the NSAP 2019 Annual Meeting and Expo held Sept. 9-12 in Washington, D.C. This poster was a combined effort between Therigy and UAB Medicine. Our team, consisting of Matthew Malachowski, PharmD, BCPS, UAB Medicine, Lily Duong, PharmD, RPh, Chief Clincal Officer at Therigy, Khang Tran, PharmD, Therigy, and Abbas Dewji, PharmD, Therigy, presented an all-new study "Coupling Patient Care Management Operations with Technology and Data Platform to Optimize Hepatitis C Therapy Outcomes."
This study followed 209 Hepatitis C patients at UAB Medicine for a 9-month period. The poster highlights how the pharmacists were able to engage with patients utilizing a monthly monitoring plan for each patient, access and support with the clinic to optimize treatment, and assessments and patient education. At the end of the study, 84% of patients reported therapy completion and actual therapy completion rate confirmed by dispensing data was 99%. SVR12 lab results were available for 69% of patients who reported completed therapy, yielding a cure rate of 98%.
The poster concludes that the pharmacy care process can be streamlined between the numerous steps and become a dynamic patient management operation. In addition, the
study demonstrated that an intuitive and robust data platform can greatly improve longitudinal follow-up and HCV cure rate measurement.
You can download a copy of the poster by filling out the form to the right.
If you are interested in more information on outcomes or quality initiatives, learn more here.